Marker Therapeutics, Inc. (MRKR)
Market Open
26 Oct, 06:37 PM
$
0. 92
-0.04
-4.1766%
$
17.34M Market Cap
- P/E Ratio
- Div Yield
180,570 Volume
0 Eps
$ 0.96
Previous Close 
Want to track MRKR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Marker Therapeutics, Inc. (MRKR) Statistics
Valuation metrics
Market Cap 17.34M
Enterprise value 4.68M
Trailing P/E (ttm) -2
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) 12.98
Price/Book (mrq) 1.52
Enterprise Value/Revenue 3.79
Enterprise Value/EBITDA -0.54
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 309.51K
Average volume (90 days) 103.27K
Price summary
52-Week low 0.84
52-Week high 2.46
Beta -
50-Day moving average 1.1
200-Day moving average 1.32
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 27 Jan 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -7.06%
Operating margin -8.69%
Operational effectiveness
Return on assets -0.6%
Return on equity -0.57%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.06
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.45
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.59
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 6.03%
Book value per share (mrq) 0.63
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
